Introduction
Colony-stimulating factor 1 (CSF-1), the primary regulator of mononuclear phagocyte production, also regulates cells of the female reproductive tract. 1, 2 The effects of CSF-1 are mediated by a high-affinity receptor tyrosine kinase (CSF-1R) [3] [4] [5] encoded by the c-fms protooncogene. 6 Complementary DNA (cDNA) clones encoding several different isoforms of both mouse and human CSF-1 have been obtained. [7] [8] [9] [10] [11] [12] Full-length CSF-1 cDNAs direct the expression of both secreted glycoprotein 13, 14 and proteoglycan 15, 16 forms, whereas the membrane-bound cell-surface form is derived from a truncated messenger RNA (mRNA) precursor in which the glycosaminoglycan addition site and the proteolytic cleavage sites yielding the secreted forms have been spliced out. 17 The N-terminal 152 amino acids of CSF-1 are required for in vitro biological activity. 1, 12 Although CSF-1 is synthesized by many different cell types in vitro, the primary source of the circulating proteoglycan and glycoprotein forms is thought to be the endothelial cells that line the small blood vessels. 18 However, CSF-1 is synthesized locally, eg, by osteoblasts 19, 20 and, during pregnancy, by uterine epithelial cells. 21 It has been suggested that regulation at particular tissue sites is mediated by local synthesis of the membrane-spanning, cell-surface CSF-1 and/or selective sequestration of the secreted proteoglycan CSF-1. 15, 16, 22 CSF-1-null Csf1 op /Csf1 op mice harbor an inactivating mutation in the coding region of the CSF-1 gene [23] [24] [25] [26] and are osteopetrotic because of their paucity of osteoclasts. 27 They are toothless, have low body weight, low growth rate, skeletal abnormalities, and are deficient in tissue macrophages. 23, [27] [28] [29] [30] In addition, they have defects in both male and female fertility, neural development, the dermis, and synovial membranes. 2 Because CSF-1R expression outside the female reproductive tract is apparently restricted to mononuclear phagocytes, 1,2 the pleiotropic phenotype of the Csf1 op / Csf1 op mouse is apparently due to a reduction in trophic and/or scavenger functions of the tissue macrophages regulated by CSF-1, secondary to the reduction of their concentration in tissues. 30 Reconstitution of circulating levels of CSF-1 in Csf1 op /Csf1 op mice, by daily subcutaneous injection of human recombinant CSF-1 from 3 days of age, partially or completely restored many tissue macrophage populations, whereas others failed to respond and were presumed to have an embryonic requirement for CSF-1, to be present at sites inaccessible to circulating CSF-1, or to be dependent on the local production of CSF-1. 30 In the present study, we have used a transgene encoding the full-length CSF-1 precursor to reconstitute circulating and tissue levels of secreted CSF-1 and some cell-surface CSF-1 expression. We have established that the forms of CSF-1 encoded by this precursor, when expressed in an essentially normal tissue-specific and developmental pattern, correct the defects reported in Csf1 op /Csf1 op mice, confirming that all the phenotypes found in these mice are due to the absence of CSF-1 and not due to a linked secondary mutation. We have identified regulatory regions of the CSF-1 gene that confer normal tissuespecific expression of CSF-1 and used these to drive expression of the lacZ gene, pinpointing sites of local CSF-1 production in tissues.
Materials and methods

Animals
Osteopetrotic Csf1 op /Csf1 op mice, CSF-1 transgenic Csf1 op /Csf1 op and littermate controls (ϩ/ϩ or ϩ/Csf1 op ), as well as the lacZ transgenic mice were bred and maintained on a segregating (C57BL/6J ϫ C3Heb/FeJ-a/a) background behind a barrier. Csf1 op /Csf1 op mice were identified by the absence of incisor eruption at 10 days of age and were fed a powdered mixture of mouse food ad libitum and infant formula (Enfamil) daily. Transgenic mice and control mice received mouse chow.
Transgene constructs and production of transgenic animals
For the TgN(FLCsf1)Ers transgene construct, a -phage insert containing 6.4 kilobases (kb) of the mouse CSF-1 promoter (3.13 kb), 31 exon 1, and the first intron (3.28 kb) was fully sequenced and subcloned, in stages, into a pGEM 3Z-based plasmid containing exons 2 to 9 of mouse CSF-1 cDNA from pGEM2MCSF53 10 together with human growth hormone (hGH) poly(A) addition sequences obtained from plasmid pOGH 32 (Figure 1 ). The hGH poly(A) sequences were included to ensure proper processing of the transgene mRNA. High concentrations of CSF-1 were detected in the culture medium from Csf1 op /Csf1 op fibroblasts transfected with the construct. The CSF-1 transgene was excised from the vector by digestion with BglII and EcoRI enzymes and the purified, linearized DNA injected into fertilized oocytes of C57BL/6 ϫFVB F1 mice. Of 3 founder mice, 2, TgN(FLCsf1)2Ers/ϩ and TgN(FLCsf1)4Ers/ϩ, transmitted the transgene to progeny, which were mated to ϩ/Csf1 op mice to generate Csf1 op /Csf1 op ; TgN(FLCsf1)Ers/ϩ and littermate control (ϩ/ϩ, ϩ/Csf1 op , and Csf1 op / Csf1 op ) mice. For the TgN(Csf1-Z)Ers transgene construct, the ATG start codon in the CSF-1 promoter/intron 1 fragment was mutated by polymerase chain reaction (PCR)-based in vitro mutagenesis and the mutated fragment cloned upstream of a lacZ gene cassette 33 containing the ATG start codon, a nuclear localization sequence, lacZ coding region, and SV40 poly(A) addition sequence ( Figure 1) . One founder mouse, TgN(Csf1-Z)1Ers/ϩ, obtained as described above, transmitted the transgene to progeny.
Genotypic analysis
Genotype analysis of the chromosomal Csf1 op allele in transgenic animals and their nontransgenic littermates was carried out by PCR using primers P1 (CGCATGGTCTCATCTATTATGTCTTG) and P2 (GAATACAGGAAC-CAGGAGGTTAGCACCTGG). These oligonucleotides respectively match sequences upstream and downstream of the Csf1 op mutation site in exon 4 ( Figure 1A ). The resulting 130-base pair (bp) Csf1 and 131-bp Csf1 op PCR products were separated in acrylamide sequencing gels. PCR products were detected either by the incorporation of 35 S dATP in the PCR reaction followed by autoradiography or, alternatively, by labeling one of the amplimers with a fluorescent dye (6-Fam, Applied Biosystems, Foster City, CA) for automated detection using a long-range automated sequencer (Perkin Elmer-Applied Biosystems, Foster City, CA).
Founder mice expressing the CSF-1 transgene were first detected by Southern hybridization of mouse tail DNA samples digested with DraIII and probed with a 32 P-labeled CSF-1 cDNA insert from plasmid pGEM2MCSF53. 10 Subsequent TgN(FLCsf1)Ers transgene genotype analysis was carried out by multiplex PCR using primers P3 (GCAGCTGTTA-AAACTAATGTGATCTTAATC) and P4 (ATGAGGACAGACAGGTG-GAACTGCCAGTAATGAAG) to detect transgene ( Figure 1B) .
Expression of TgN(Csf1-Z)1Ers was detected using primers P5 (CCCAACTTAATCGCCTTGCAGCACATCCCC) and P6 (CTGCCAGTT-TGAGGGGACGACGACAGTATC) ( Figure 1C ).
Measurement of CSF-1
CSF-1 was measured by radioimmunoassay. 34, 35 Tissue extracts were prepared from exsanguinated mice as described elsewhere. 36 Cell-surface CSF-1 was measured by flow cytometry (below) and by trypsin release of intact CSF-1 followed by radioimmunoassay.
Analyses of mRNAs
Ribonuclease protection assays (RPAs) were carried out using an RPA II kit (Ambion, Austin, TX) by probing 10 g of DNase1-treated total tissue RNA with 32 P-labeled RNA probes synthesized using a MAXIscript Sp6/T7 kit (Ambion) from linearized PCR-vector (Invitrogen, Carlsbad, CA)-based intermediate plasmid DNA, in which PCR products for the exon 9/hGH RPA probe (from the BamHI site of exon 6 to the SmaI site of the hGH untranslated region [UTR], including the hGH poly(A) addition site, Figure 1B ) and exon 10 probe ( Figure 1A ) were amplified from TgN(FLCsf1)Ers DNA and pGEM2MCSF10 DNA, 10 respectively.
X-ray analysis of mouse skeletal structure
Radiographs were produced by exposing euthanized or anesthetized mice in a Faxitron pathology specimen x-ray cabinet (Faxitron X-Ray, Buffalo Grove, IL). The animals were posed immediately above a fine-grained Polaroid 665 instant-negative film package. Exposure was set at 50 kV for 1.5 minutes. The negatives were developed and printed according to the manufacturer's instructions (Polaroid, Cambridge, MA).
Immunohistochemistry, histochemistry, and flow cytometry
For immunostaining with rat monoclonal antibody F4/80 37 and histochemical localization of tartrate-resistant acid phosphatase (TRAP), siblings of For personal use only. on November 16, 2017 . by guest www.bloodjournal.org From the different genotypes were perfused and tissues fixed, decalcified (knee joint only), embedded, sectioned, and immunostained as described. 30 F4/80 ϩ cells in tissue sections of at least 2 mice of a particular genotype at each age were quantitated as described. 30 For localization of ␤-galactosidase, 5-mm tissue cubes were fixed and stained by incubation with 4-chloro-5-bromo-3-indolyl-b-D-galactopyranoside as described. 38 Alternate 5-and 20-mm sections were used for hematoxylin and eosin (H&E) staining and for observation of ␤-galactosidase localization, respectively. For all of the tissues shown, there was minimal ␤-galactosidase staining in nontransgenic tissues. For flow cytometry analysis of cell-surface CSF-1, single-cell suspensions of primary skin fibroblasts were made from ϩ/ϩ, ϩ/Csf1 op , Csf1 op /Csf1 op , and Csf1 op /Csf1 op ; TgN(FLCsf1)2Ers/ϩ mice and incubated sequentially with rat antimouse CSF-1 YYG106 monoclonal (2 g/10 6 cells) 35 and phycoerythrin-goat antirat and phycoerythrinconjugated rabbit antigoat antibodies. Fluorescence-activated cell sorter (FACS) analyses were done with a Becton Dickinson FACSCalibur (San Jose, CA) in the FACS facility of Albert Einstein College of Medicine.
Hematopoietic parameters
Red cell lysis, antibody staining (FITC-CD45.2 and PerCp-B220, Pharmingen, San Diego, CA), and FACS and data analysis of heparinized blood samples were standard procedures carried out as described. 39 Spleen and bone marrow cell suspensions were assayed for colony-forming cells of high proliferative potential (HPP-CFC) and low proliferative potential (CFU-C) as previously described. 40 BFU-E (burst-forming unit-erythroid) and CFU-GEMM (colony-forming unit-granulocyte, erythroid, macrophage, megakaryocyte) assays were performed using reagents supplied by Stem Cell Technology, as described by the manufacturers (Stem Cell Technologies, Vancouver, BC, Canada). (Table 1) . However, the serum CSF-1 concentrations of Csf1 op /Csf1 op ; TgN(FLCsf1)4Ers/ϩ mice, containing about 4 times higher levels of the transgene, were 3 times those of ϩ/Csf1 op mice (Table 1) The CSF-1-null Csf1 op /Csf1 op mice exhibit impaired bone resorption associated with a reduction in the number of osteoclasts. 27 Their inability to remodel bone results in skeletal deformities, particularly in the long bones, which are dense, short, and thick ( Figure 3G ); in the flat bony plates, which produce their characteristically domed skull ( Figure 3C) ; and in the mandible, resulting in a failure of tooth eruption ( Figure 3C ). These gross skeletal defects were completely restored by expression of either transgene (compare Figure 3F ,D with Figure 3E ,B). Upper and lower incisor tooth eruption, absent in Csf1 op /Csf1 op mice ( Figure 3C ), occurred on postnatal days 9 and 10 after birth in both ϩ/Csf1 op and transgenic Csf1 op /Csf1 op mice ( Figure 3B,D) . In contrast to the sometimes abnormally curved or misaligned ( Figure 3A ) incisor teeth of Csf1 op /Csf1 op mice injected daily with CSF-1 from the third postnatal day, 30 incisor teeth of the transgenic Csf1 op /Csf1 op mice always appeared to be normal and properly aligned ( Figure 3D ). The decreased head size and shortening of the facial bones ( Figure  3C ), the stubby appearance of the tarsals and metatarsals, and the appearance of the femur and humerus ( Figure 3G ) in the Csf1 op / Csf1 op mice were also restored to normal by transgene expression Csf1 op /Csf1 op male mice have low testosterone levels, a low libido, and reduced viable sperm numbers compared with normal males and mate infrequently, displaying a long latency between mating when presented serially with female mice in estrus. 45 Restoration of normal male libido was apparent in Csf1 op /Csf1 op ; TgC/ϩ mice, which mated frequently with cycling females and produced plugged females on successive days following daily exposure to different superovulated females (data not shown).
Results
Circulating
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Expression of TgC transgene mRNA
A labeled RNA probe covering exon 9 and hGH sequences that allowed the simultaneous comparison of endogenous and transgenic CSF-1 mRNA by RPA ( Figure 1B) revealed that the CSF-1 transgene mRNA was detected in each of the tissues examined ( Figure 5A ). However, the amount of transgene-specific mRNA containing the hGH sequences was low compared with that of the endogenous exon 9-containing CSF-1 mRNA. Because the ratio of the 2.0-kb exon 9-containing CSF-1 mRNA to the 4.0-kb exon 10-containing CSF-1 mRNA is lower in tissues of Csf1 op /Csf1 op mice than in ϩ/ϩ mice, 23, 26 the high levels of exon 9-containing mRNA detected in Csf1 op /Csf1 op ; TgC/ϩ tissues ( Figure 5A ) prompted us to use an exon 10 probe ( Figure 1A ) with the exon 9/hGH probe to examine the relative contributions of the alternatively spliced exon 9-and exon 10-containing versions of CSF-1 mRNA in Csf1 op /Csf1 op ; TgC/ϩ, wild-type, and Csf1 op /Csf1 op mice ( Figure 5B ). This comparison demonstrated a much higher ratio of exon 9-to exon 10-containing mRNA in the tissues of Csf1 op /Csf1 op ; TgC/ϩ mice than in the tissues of their Csf1 op /Csf1 op littermates ( Figure 5B , right panel), indicating that the high expression of exon 9 mRNA relative to the transgene in Figure 5A is due to use of the endogenous CSF-1 poly(A) addition site upstream of the hGH poly(A) addition sequences in the transgene. Thus, the CSF-1 transgene mRNA is expressed at sufficiently high levels to explain the normalization of CSF-1 in most tissues of Csf1 op /Csf1 op ; TgC/ϩ mice. 30 To assess whether expression of TgC in Csf1 op /Csf1 op mice reconstituted F4/80 ϩ macrophage expression in these tissues, F4/80 ϩ macrophages in Csf1 op /Csf1 op ; TgC/ϩ, Csf1 op /Csf1 op , and normal (ϩ/Csf1 op ) mice were quantified in tissues prepared from mice at the ages where the F4/80 ϩ macrophage density had previously been shown 30 to be maximum for the particular wild-type tissue (Table 3 ). Previous studies showed that injected CSF-1 is unable to restore F4/80 ϩ macrophages, which colonize the adrenal gland and dense connective tissues including tendon, striated muscle, deep dermis, synovium, and periosteum. 30 F4/80 ϩ macrophages in these tissues are completely recovered in the tissues of Csf1 op /Csf1 op ; TgC/ϩ mice, being present at slightly TgC and endogenous CSF-1 mRNAs in 10 g aliquots of total RNA were quantitated by RPA using the exon 9/hGH and exon 10 cDNA probes illustrated in Figure  1A ,B. (A) Messenger RNA products protected by the exon 9/hGH probe, which correspond to the exon 9 UTR-containing CSF-1 mRNA (exon 9) and the hGH poly(A) UTR-containing TgC mRNA (Transgene), are indicated. TgC mRNA was detected in each of the tissues examined, apparently at low levels compared with the levels of endogenous CSF-1 mRNA. All samples were electrophoresed in the same gel and the data captured by phosphoimager; intensity of bands in the lower portion of the figure has been reduced to improve resolution. (B) RPA of RNA samples from selected tissues of mice of the indicated genotype, using the exon 9/hGH and exon 10 cDNA probes. Bands representing the exon 9-and exon 10-containing transcripts are indicated. The exon 9 probe generally detects 2 CSF-1-specific bands. Table 3 ). Tissues containing CSF-1-dependent F4/ 80 ϩ macrophages that are only partially restored by injection of CSF-1 include bladder, sublingual salivary gland, stomach, and villus cores of the small intestine and large intestine. 30 With the exception of bladder, which showed a partial response to expression of TgC, F4/80 ϩ macrophages in these tissues were also restored to at least normal levels ( Figure 6 , Table 3 ). Tissues in which F4/80 ϩ macrophages attained at least normal levels with restoration of circulating CSF-1 by injection included tissues such as kidney, liver, and spleen. F4/80 ϩ macrophages were restored to normal levels in these tissues in Csf1 op /Csf1 op ; TgC/ϩ mice ( Figure 6 ) were slightly higher (Table 3 ). These data indicate that TgC confers approximately normal regulation of the development of all CSF-1-dependent F4/80 ϩ tissue macrophage populations examined.
Normalization of hematopoietic parameters in Csf1 op /Csf1 op ; TgC/؉ mice
To examine the hematopoietic status of the Csf1 op /Csf1 op ; TgC/ϩ mice, bone marrow, spleen, and hematopoietic progenitor cell numbers were determined at 6 weeks of age (Table 4 ). The reduced bone marrow cellularity of Csf1 op /Csf1 op mice was restored to normal by expression of TgC. Consistent with their reduced space for marrow hematopoiesis and in agreement with their reported compensatory splenic hematopoiesis, 40 the splenic cellularities of 6-week-old Csf1 op /Csf1 op mice were significantly elevated compared with those of ϩ/Csf1 op mice. As expected from their normal bone marrow cellularity, these parameters in Csf1 op /Csf1 op ; TgC/ϩ mice were indistinguishable from those of ϩ/Csf1 op mice. In agreement with previous reports, 28, 47 blood monocyte and lymphocyte percentages were reduced in Csf1 op /Csf1 op mice and, consistent with one other report, 48 blood granulocyte percentages were increased. All these changes were normalized in the blood of the Csf1 op /Csf1 op ; TgC/ϩ mice ( Figure 7 , Table 4 ). Previous studies have shown that the Csf1 op mutation does not alter the relative frequency of BFU-E, CFU-GEMM, HPP-CFC, or CFU-C progenitor cells in the bone marrow. 40 There was no significant difference in the frequency of these various progenitors in the bone marrows of Csf1 op /Csf1 op ; TgC/ϩ, Csf1 op /Csf1 op , and ϩ/Csf1 op mice ( Table 4) .
Localization of in vivo sites of CSF-1 synthesis
TgC drives relatively normal tissue-specific and developmental expression of CSF-1 and corrects all the major aspects of the Csf1 op /Csf1 op phenotype. To rapidly identify CSF-1-synthesizing Figure 1C ). Two transgenic founder mice were obtained, only one of which transmitted the transgene. TgZ/ϩ mice showed no abnormal phenotype and were used exclusively for this study.
Analysis of the expression of ␤-galactosidase was carried out in hematopoietic (Figure 8 ), reproductive ( Figure 9 ), and other ( Figure 10 ) tissues from normal 7-week-old wild-type mice expressing TgZ. In hematopoietic tissues (Figure 8 ), cells expressing ␤-galactosidase were found in splenic red pulp and marginal zone ( Figure 8A ,B) and in outer cortical regions of the lymph node, where macrophages are concentrated and were excluded from the white pulp and germinal centers that are relatively devoid of macrophages ( Figure 8C,D) . 30 In thymus, positive cells were scattered within the cortex, an area rich in macrophages ( Figure  8E,F) . In the bone marrow ( Figure 8G-I) , the location and shape of the ␤-galactosidase-expressing cells were characteristic of bone marrow stromal fibroblasts and osteoblasts previously shown to synthesize CSF-1. 49, 50 Expression of ␤-galactosidase recapitulated previously documented sites of synthesis in the uterus and ovary and revealed new sites of expression in the mammary gland ( Figure 9 ). In mammary gland, there was extensive staining of the entire ductal network ( Figure 9C ) with strong staining in the terminal end buds ( Figure  9B ) but with minimal expression in the fat pad. Expression was also seen in the blood vessels and lymph node (Figure 9B-D) . Ductal expression was maintained during arborization early in pregnancy ( Figure 9D ). In the uterus, the ␤-galactosidase expression was restricted to epithelial cells of uteri of both nonpregnant ( Figure 9E ,F) and day 6 pregnant mice ( Figure 9G,H) , increasing with pregnancy, as previously reported for CSF-1 synthesis by this epithelium 21 (Table 2 ). Focal staining of individual cells was also observed in the myometrium of the pregnant uteri, particularly close to the mesometrial attachment ( Figure 9G) . Expression of ␤-galactosidase in the ovary was restricted to the granulosa cells of Table 5 . At least three 6-to 8-week-old mice per experimental group. Data are expressed as means Ϯ SEM. BFU-E and CFU-GEMM: 1.5 ϫ 10 4 cells per plate (n ϭ 6); HPP-CFC: 2.5 ϫ 10 3 cells per plate (n ϭ 6); and CFU-C: 1 ϫ 10 4 cells per plate (n ϭ 9).
BFU-E indicates burst-forming unit-erythroid; CFU-GEMM, colony-forming unitgranulocyte, erythroid, macrophage, megakaryocyte; HPP-CFC, colony-forming cells of high proliferative potential; CFU-C, colony-forming cells of low proliferative potential.
*From FACS analyses ( Figure 7) . Differences between Csf1 op /Csf1 op ; TgC/ϩ and Csf1 op /Csf1 op mice significant (P Ͻ .01) and differences between Csf1 op /Csf1 op ; TgC/ϩ and ϩ/Csf1 op not significant (P Ͼ .05) by Student t test.
†Differences not significant within assays (P Ն .05) by Student t test. the developing follicles, with no expression observed in the oocyte ( Figure 9I,J) . New sites of CSF-1 synthesis are also indicated for other tissues (Figure 10 ). The ␤-galactosidase stained Paneth cells at the base of the crypts of the small intestine ( Figure 10A,B) close to regions of CSF-1-dependent macrophage localization in the muscularis externa 51 and, similarly, in the base of the crypts of the pyloric glands of the stomach (Figure 10C,D) . There was strong positive staining of serous acinar cells of the salivary gland ( Figure 10E ,F) adjacent to and on the basal side of which F4/80 ϩ macrophages reside ( Figure 6N ,O) and consistent with the high CSF-1 content of this gland. 36 The zona reticularis of the adrenal gland ( Figure 10G,H) and the neck of the sebaceous gland also contained ␤-galactosidaseexpressing cells (Figure 10I,J) . In testis, there was staining of interstitial cells ( Figure 10K,L) , regions of Leydig cell, and CSF-1-dependent macrophage colocalization. 46, 52 Also, ␤-galactosidase staining of the epithelial cells of the proximal convoluted tubules of the kidney and of the blood vessels and cortex of the brain was observed (data not shown).
Discussion
We have shown that expression of a transgene encoding full-length CSF-1 under the control of 3.13 kb of the CSF-1 promoter and first intron completely corrected the gross defects of the CSF-1-null Csf1 op /Csf1 op mouse, including the osteopetrotic, neurologic, weight, skeletal, tooth eruption, hematopoietic, and reproductive defects. Save for overexpression in 4 tissues, it normalized CSF-1 expression in the circulation and in tissues, including uterus during pregnancy, where CSF-1 expression is dramatically increased. In addition, expression of the transgene restored tissue F4/80 ϩ macrophage densities in a temporally correct fashion. These results suggest that this transgene provides all the forms of CSF-1 necessary for normal regulation of both locally and humorally regulated target cells. This point is emphasized in Table 5 , which summarizes the relative incompleteness of the reconstitution of F4/80 ϩ macrophage densities in Csf1 op /Csf1 op mice injected with CSF-1, compared with those expressing the transgene.
The exon 9 poly(A) addition signal was used quite efficiently in the transgene, although transcripts derived from use of the hGH poly(A) addition signal were present in each tissue examined. The exon 10 3Ј UTR contains AU-rich repeats, absent in exon 9, that in the right context confer a short half-life on mRNAs. 10, 53 Thus, the high levels of expression of CSF-1 in the secretory organs, bladder, testes/epididymis, prostate, and salivary glands may result from the use of the exon 9 3Ј UTR in the transgene, because the levels of mRNA for 2 of the 4 tissues examined, testis and salivary gland, are significantly elevated over their expression in ϩ/Csf1 op mice.
Although the detailed data presented here are analyses of a single CSF-1 transgenic line, an identical gross phenotype was observed with a second independent line that expressed 3-fold higher levels of circulating CSF-1. In addition, we have recently used the same CSF-1 promoter/intron 1 region to drive expression of another form of CSF-1 encoded by a truncated CSF-1 cDNA and have shown that it has a similar pattern of tissue expression (data not shown). For the above reasons, we believe that the pattern of tissue CSF-1 expression driven by the promoter/first intron is position-and copy number-independent. Furthermore, as we have also shown here, this regulatory region drives expression of a lacZ reporter gene specifically in all previously documented sites of local CSF-1 synthesis within tissues. Thus, the 3.13-kb CSF-1 promoter/first intron are apparently sufficient to regulate normal CSF-1 gene expression. Previous studies of the regulation of CSF-1 gene expression have utilized CSF-1 reporter constructs containing 774 bp of the mouse CSF-1 promoter transfected into fibroblasts, monocytes, osteoblast-like, and COS-7 cell lines. 54, 55 Several putative trans-acting factors for cis-acting elements in this region of the promoter have been identified, 54 and it has been shown that expression in different cell types is mediated by common and by cell type-specific transcription factors. 54, 56 However, the minimal promoter length required for normal tissue-specific and developmental expression has not been established, and modulation of CSF-1 gene expression by parathyroid hormone (PTH), tumor necrosis factor-␣, Il-1␣, and 1,25 (OH) 2 D3 observed in vivo is not reproduced with the 774-bp promoter construct. 55 The present studies establish regulatory regions required for normal CSF-1 gene expression that can be further investigated by deletion/mutation.
Although previous experiments involving transfection of the full-length exon 10-containing CSF-1 cDNA into NIH3T3 cells failed to demonstrate cell-surface expression of the more truncated glycoprotein, the expression of the larger more prominent proteoglycan was not studied. 13 Consistent with our observation of cell-surface expression in Csf1 op /Csf1 op ; TgC/ϩ fibroblasts, others have demonstrated cell-surface expression in COS-7 cells expressing full-length CSF-1 cDNA. 11 Whether the surface expression is due to a membrane-spanning or membrane-associated CSF-1 remains to be established.
As indicated above (Table 5) , restoration of circulating CSF-1 in Csf1 op /Csf1 op mice by daily injection of CSF-1 was only partially successful in correcting the Csf1 op /Csf1 op defects, suggesting that either CSF-1 must be given embyronically, be synthesized locally, be expressed on the surface of cells, contain the correct glycosaminoglycan as the proteoglycan form, or various combinations of these possibilities for complete correction of the Csf1 op /Csf1 op defects to occur. The present successful correction by the fulllength transgene is likely to have satisfied all of these putative requirements but is unable to resolve which requirement is necessary for correction of each particular defect. Using this promoter/intron combination to drive appropriate CSF-1 cDNAs, it should be possible to independently investigate the roles of the secreted glycoprotein, secreted proteoglycan, and cell-surface forms of the growth factor.
The pattern of the transgenic expression of ␤-galactosidase under the control of the same CSF-1 promoter/first intron driver also indicates that the TgC transgene correctly directs local tissue expression of CSF-1. First, ␤-galactosidase was expressed at several tissue locations shown to synthesize CSF-1 by in situ hybridization or immunohistochemical/cell culture approaches. Thus, CSF-1 is synthesized in the uterine glandular epithelium of pregnant mice, 21 bone marrow fibroblasts 57 and osteoblasts, 19, 20 endothelial cells, 18 and ovarian granulosa cells (K. Nishimura, P. Cohen, L. Zhu, and J.W.P., unpublished data, August 1997), all sites shown to express ␤-galactosidase in TgZ/ϩ mice. Second, ␤-galactosidase was expressed at several additional tissue locations in which CSF-1-responding cells are localized but which have not been previously reported to synthesize CSF-1, including the ductal epithelium of the mammary gland, 58 the myometrium, 59 testicular Leydig cells, 46 the marginal zone 60 and red pulp 30 of the spleen, the cortex and medulla of the lymph node, the cortex of the thymus, the base of the crypts of the small intestine, stomach, and sublingual salivary gland, 30, 51 and the cortical tubules of the kidney. 61 Local synthesis of CSF-1 is apparently responsible for macrophage regulation and/or presence at these sites.
Analysis of TgZ/ϩ mice suggests that synthesis of CSF-1 occurs at several novel sites besides those mentioned above, in which CSF-1-responding cells are localized. These sites include cells in the cortex and hypothalamus of the brain, cells in the zona reticularis of the adrenal gland, and cells in the neck of the sebaceous gland. Analysis of the role of CSF-1 synthesis at these sites and the sites mentioned above, in which CSF-1 synthesis juxtaposes CSF-1-responding cells, should greatly increase our understanding of local regulation by this growth factor.
Previous studies with Csf1 op /Csf1 op mice have indicated that CSF-1 target cells have important scavenger (eg, osteoclasts 62 ), trophic (eg, testicular macrophages 42, 46, 52 ) , and immunologic (eg, trophoblasts 63 ) roles in the development, maintenance, and function of the tissues in which they reside. Given the restricted distribution of the CSF-1 receptor to mononuclear phagocytes and cells of the female reproductive tract, 1,2 such functions explain the pleiotropic nature of the Csf1 op mutation. 30 The present analysis of the TgZ mouse contributes significantly to our understanding of the local regulation of these cells. Consider, for example, reproduction. CSF-1 maintains ovulation rates and recruits macrophages to the growing follicle 43 and to the uterine stroma during the estrus cycle. 59 The uterine CSF-1 is locally synthesized from epithelial cells, which synthesize it in response to estrogen and, during pregnancy, progesterone. 21, 59 During pregnancy, its action on the trophoblast is necessary for effective immunologic responses to pathogens at the uteroplacental unit. 63 Expression of ␤-galactosidase recapitulated the previously demonstrated expression of CSF-1 in granulosa cells surrounding the developing follicle and in uterine luminal and glandular epithelial cells 21, 64 (L. Zhu and J.W.P., manuscript in preparation, August 1997). The relative failure of mammary epithelial development in Csf1 op /Csf1 op mice, 44 characterized by a paucity of macrophages surrounding the terminal end buds, a low rate of ductal outgrowth, and fewer ductal branches, can be partially reversed by ductal epithelial expression of CSF-1 (A. V. Nguyen and J.W.P., manuscript in preparation, August 2000). The ␤-galactosidase expression in the mammary ductal tree and particularly the terminal end buds suggests that CSF-1 derived from these epithelial cells recruits macrophages to the developing structure where they enhance ductal outgrowth and development. In testis, each CSF-1-dependent macrophage (absent in Csf1op/Csf1op mice) contacts an average of 4 Leydig cells, apparently enhancing testosterone synthesis by the Leydig cells. 45, 46 Expression of ␤-galactosidase by Leydig cells indicates that their expression of CSF-1 is responsible for macrophage recruitment to the interstitium. Similar CSF-1 regulatory roles can be envisaged for the cells we have shown to synthesize ␤-galactosidase in nonreproductive tissues.
